# Adma Biologics, Inc.: Form 8-K, filed Jun 21, 2022

- Company: [Adma Biologics, Inc.](/companies/adma.md) (CIK 1368514)
- Form: 8-K
- Filed: 2022-06-21
- Accepted by EDGAR: Jun 21, 2022, 17:00 ET
- Period: 2022-06-21
- Accession: 0001140361-22-023666
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1368514/000114036122023666/brhc10038967_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1368514/000114036122023666/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1368514/000114036122023666/brhc10038967_8k.htm

Filed Jun 21, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-023666. Last ingested by Listed: Nov 10, 2026, 16:34 ET. No prices; not investment advice.
